These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9059668)

  • 1. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
    Shimizu H
    Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism by an electron microscopic dopa reaction test of fetal skin.
    Shimizu H; Ishiko A; Kikuchi A; Akiyama M; Suzumori K; Nishikawa T
    Prenat Diagn; 1994 Jun; 14(6):442-50. PubMed ID: 7937580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-based carrier detection and prenatal diagnosis of tyrosinase-negative oculocutaneous albinism (OCA1A).
    Falik-Borenstein TC; Holmes SA; Borochowitz Z; Levin A; Rosenmann A; Spritz RA
    Prenat Diagn; 1995 Apr; 15(4):345-9. PubMed ID: 7617575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene.
    Shimizu H; Niizeki H; Suzumori K; Aozaki R; Kawaguchi R; Hikiji K; Nishikawa T
    J Invest Dermatol; 1994 Jul; 103(1):104-6. PubMed ID: 8027570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopa reaction test in hair bulbs of fetuses and its application to the prenatal diagnosis of albinism.
    Gershoni-Baruch R; Benderly A; Brandes JM; Gilhar A
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):220-2. PubMed ID: 1901069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prenatal gene diagnosis of oculocutaneous albinism type I].
    Li HY; Wu WI; Zheng H; Duan HL; Chen Z; Chen LM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):280-2. PubMed ID: 16767664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based prenatal diagnosis of a Korean family with tyrosinase-related oculocutaneous albinism (OCA1).
    Lee ST; Park SK; Lee H; Lee JS; Park YW
    Jpn J Hum Genet; 1997 Dec; 42(4):499-505. PubMed ID: 9560949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of inherited skin diseases.
    Shimizu H
    Keio J Med; 1996 Mar; 45(1):28-36. PubMed ID: 8882465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
    Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal molecular diagnosis of oculocutaneous albinism (OCA) in a large cohort of Israeli families.
    Rosenmann A; Bejarano-Achache I; Eli D; Maftsir G; Mizrahi-Meissonnier L; Blumenfeld A
    Prenat Diagn; 2009 Oct; 29(10):939-46. PubMed ID: 19626598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
    Giebel LB; Musarella MA; Spritz RA
    J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of oculocutaneous albinism by electron microscopy of fetal skin.
    Eady RA; Gunner DB; Garner A; Rodeck CH
    J Invest Dermatol; 1983 Mar; 80(3):210-2. PubMed ID: 6827132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
    Oetting WS; Fryer JP; King RA
    Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early prenatal genetic diagnosis of oculocutaneous albinism type I in seven families].
    Wu Q; Shi HR; Liu N; Lu N; Jiang M; Zhao ZH; Kong XD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):377-81. PubMed ID: 22875490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
    Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
    Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.